APA (7th ed.) Citation

Leng, Y., Zhang, Y., Cheng, Y., Ye, S., Zheng, Y., He, M., . . . Zhang, H. (2025). LIX1L aggravates MASH-HCC progression by reprogramming of hepatic metabolism and microenvironment via CD36. Pharmacological research, 211, 107567. https://doi.org/10.1016/j.phrs.2024.107567

Chicago Style (17th ed.) Citation

Leng, Yingrong, Yanqiu Zhang, Yang Cheng, Shengtao Ye, Ying Zheng, Mengmeng He, Enyi Wu, Lingyi Kong, and Hao Zhang. "LIX1L Aggravates MASH-HCC Progression by Reprogramming of Hepatic Metabolism and Microenvironment via CD36." Pharmacological Research 211 (2025): 107567. https://doi.org/10.1016/j.phrs.2024.107567.

MLA (9th ed.) Citation

Leng, Yingrong, et al. "LIX1L Aggravates MASH-HCC Progression by Reprogramming of Hepatic Metabolism and Microenvironment via CD36." Pharmacological Research, vol. 211, 2025, p. 107567, https://doi.org/10.1016/j.phrs.2024.107567.